Holst Olsen, I. (2012) “First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: A single institution experience”, Acta Oncologica, 51(1), pp. 97–100. doi: 10.3109/0284186X.2011.582881.